Daikin provides HFA 227, in a special pharmaceutical grade as SOLKANE™ 227ea/P, specifically for use in medical products. It is produced at the highest quality as required by administration via inhalation to the lung.
HFA Propellant for Medical Sprays
SOLKANE™ 227ea/P also known as apaflurane is used in medical sprays such as MDIs (Metered Dose Inhalers, also called asthma sprays or pharmaceutical aerosols inhaled by the patient), and other FDA-approved uses to propel the active ingredient which is dispersed or solubilized in the hydrofluoroalkane (hereinafter referred to as HFA propellant). HFA 227 does not contain chlorine and is thus non-ozone depleting. Furthermore, it‘s non flammable and chemically inert. This makes it, from a safety and toxicological point of view, an ideal candidate for use in medical products.
SOLKANE™ 227ea/P Special Pharmaceutical Grade
- MDIs (Metered Dose Inhalers), also known as
pharmaceutical aerosols or asthma sprays, for the treatment of:
asthma, COPD (Chronic Obstructive Pulmonary Disorder)
and respiratory infections
- Other FDA approved uses
- 25 years of production
- Global supply chain
- Quality excellence
- Daikin HFA 227ea/P has been used in millions of inhalers
- Security of availability through 2036 and beyond, under the
- US AIM Act and the EU F-Gas Regulation